CoChat

BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2

Open access
Nishitomi, Kouhei, Sakaguchi, Gaku, Horikoshi, Yuko, Gray, Audrey J., Maeda, Masahiro, Hirata‐Fukae, Chiho, Becker, Amanda G., Hosono, Motoko, Sakaguchi, Isako, Minami, S. Sakura, Nakajima, Yoshihiro, Li, Hui‐Fang, Takeyama, Chie, Kihara, Tsuyoshi, Ota, Akinobu, Wong, Philip C., Aisen, Paul S., Kato, Akira, Kinoshita, Noriaki, Matsuoka, Yasuji · 2006 · Journal of Neurochemistry
Cited by 97

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Accumulation of amyloid beta peptide (Abeta) in brain is a hallmark of Alzheimer's disease (AD). Inhibition of beta‐site amyloid precursor protein (APP)‐cleaving enzyme‐1 (BACE1), the enzyme that initiates Abeta production, and other Abeta‐lowering strategies are commonly tested in transgenic mice overexpressing mutant APP. However, sporadic AD cases, which represent the majority of AD patients, are free from the mutation and do not necessarily have overproduction of APP. In addition, the commonly used Swedish mutant APP alters APP cleavage. Therefore, testing Abeta‐lowering strategies in transgenic mice may not be optimal. In this study, we investigated the impact of BACE1 inhibition in non‐transgenic mice with physiologically relevant APP expression. Existing Abeta ELISAs are either relatively insensitive to mouse Abeta or not specific to full‐length Abeta. A newly developed ELISA detected a significant reduction of full‐length soluble Abeta 1–40 in mice with the BACE1 homozygous gene deletion or BACE1 inhibitor treatment, while the level of x‐40 Abeta was moderately reduced due to detection of non‐full‐length Abeta and compensatory activation of alpha‐secretase. These results confirmed the feasibility of Abeta reduction through BACE1 inhibition under physiological conditions. Studies using our new ELISA in non‐transgenic mice provide more accurate evaluation of Abeta‐reducing strategies than was previously feasible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2006.04178.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 97

Metadata

Authors
Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A. J., Maeda, M., Hirata‐Fukae, C., Becker, A. G., Hosono, M., Sakaguchi, I., Minami, S. S., Nakajima, Y., Li, H., Takeyama, C., Kihara, T., Ota, A., Wong, P. C., Aisen, P. S., Kato, A., Kinoshita, N., & Matsuoka, Y.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2006-08-21
Volume
99
Issue
6
Pages
1555-1563
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2130534256
Cited by
97
References
9
FWCI
3.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2. https://app.cochat.ai/papers/10.1111/j.1471-4159.2006.04178.x
The paper
Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A. J., Maeda, M., Hirata‐Fukae, C., Becker, A. G., Hosono, M., Sakaguchi, I., Minami, S. S., Nakajima, Y., Li, H., Takeyama, C., Kihara, T., Ota, A., Wong, P. C., Aisen, P. S., Kato, A., Kinoshita, N., & Matsuoka, Y. (2006). BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2006.04178.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.